InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the detailed record of transactions filed by Fust Matthew K, Director. Officer active across 4 companies, notably Atara Biotherapeutics, Inc.. In total, 18 reports have been published. Total volume traded: €448k. The latest transaction was disclosed on 24 June 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations18 total
03,300 shares0
Common Stock
SEC:0001209191-22-039566:0·
€273,5877,500 shares@ €36.47830.011% mcap100.0% of flow
Common Stock
SEC:0001209191-22-016930:0·
€224,18113,354 shares@ €16.78760.17% mcap100.0% of flow
Common Stock
SEC:0001567619-21-019403·
€224,18113,354 shares@ €16.78760.27% mcap100.0% of flow
Common Stock
SEC:0001567619-21-019403:0·
€14,7988,954 shares@ €1.65270.0003% mcap30.3% of flow
Common Stock
SEC:0001209191-21-062728·
€14,7988,954 shares@ €1.65270.0003% mcap15.2% of flow
Common Stock
SEC:0001209191-21-062728:0·
€9,7716,046 shares@ €1.6160.0002% mcap20.0% of flow
Common Stock
SEC:0001209191-21-055314·
€9,7716,046 shares@ €1.6160.0002% mcap10.0% of flow
Common Stock
SEC:0001209191-21-055314:0·
€8,0885,000 shares@ €1.61760.0002% mcap16.6% of flow
Common Stock
SEC:0001209191-21-048375·
€8,0885,000 shares@ €1.61760.0002% mcap8.3% of flow
Common Stock
SEC:0001209191-21-048375:0·
€8,0975,000 shares@ €1.61950.0002% mcap16.6% of flow
Common Stock
SEC:0001209191-21-047402·
€8,0975,000 shares@ €1.61950.0002% mcap8.3% of flow
Common Stock
SEC:0001209191-21-047402:0·
€8,0495,000 shares@ €1.60970.0002% mcap16.5% of flow
Common Stock
SEC:0001209191-21-046554·
€8,0495,000 shares@ €1.60970.0002% mcap8.2% of flow
Common Stock
SEC:0001209191-21-046554:0·
02,145 shares0
Common Stock
SEC:0001209191-21-043540·
02,145 shares0
Common Stock
SEC:0001209191-21-043540:0·
011,000 shares0
Common Stock
SEC:0001140361-21-020432·
011,000 shares0
Common Stock
SEC:0001140361-21-020432:0·
18 of 18 declarations
About Fust Matthew K
Matthew K Fust is an executive at Atara Biotherapeutics, Inc.
